GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Cash-to-Debt

Biogena Group Invest AG (WBO:BIO) Cash-to-Debt : No Debt (1) (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Biogena Group Invest AG's cash to debt ratio for the quarter that ended in Jan. 2024 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Biogena Group Invest AG could pay off its debt using the cash in hand for the quarter that ended in Jan. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Biogena Group Invest AG's Cash-to-Debt or its related term are showing as below:

WBO:BIO' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt   Med: No Debt   Max: No Debt
Current: No Debt

During the past 4 years, Biogena Group Invest AG's highest Cash to Debt Ratio was No Debt. The lowest was No Debt. And the median was No Debt.

WBO:BIO's Cash-to-Debt is ranked better than
99.83% of 1815 companies
in the Consumer Packaged Goods industry
Industry Median: 0.52 vs WBO:BIO: No Debt

Biogena Group Invest AG Cash-to-Debt Historical Data

The historical data trend for Biogena Group Invest AG's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Biogena Group Invest AG Cash-to-Debt Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Cash-to-Debt
No Debt No Debt No Debt No Debt

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Cash-to-Debt No Debt No Debt No Debt No Debt

Competitive Comparison of Biogena Group Invest AG's Cash-to-Debt

For the Packaged Foods subindustry, Biogena Group Invest AG's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Cash-to-Debt Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Cash-to-Debt falls into.



Biogena Group Invest AG Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Biogena Group Invest AG's Cash to Debt Ratio for the fiscal year that ended in Jan. 2024 is calculated as:

Biogena Group Invest AG had no debt (1).

Biogena Group Invest AG's Cash to Debt Ratio for the quarter that ended in Jan. 2024 is calculated as:

Biogena Group Invest AG had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Biogena Group Invest AG Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.

Biogena Group Invest AG (WBO:BIO) Headlines